Total Payments
$15,897
2024 Payments
$1,736
Companies
57
Transactions
1,188
Medicare Patients
8,491
Medicare Billing
$836,584
Payment Breakdown by Category
Food & Beverage$15,409 (96.9%)
Education$487.29 (3.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,409 | 1,151 | 96.9% |
| Education | $487.29 | 37 | 3.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,330 | 91 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,088 | 65 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $1,031 | 58 | $0 (2024) |
| PFIZER INC. | $1,016 | 90 | $0 (2024) |
| Amgen Inc. | $914.24 | 61 | $0 (2024) |
| ABBVIE INC. | $907.37 | 99 | $0 (2024) |
| Allergan, Inc. | $889.39 | 119 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $847.79 | 66 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $773.13 | 73 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $515.03 | 39 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,736 | 106 | Otsuka America Pharmaceutical, Inc. ($278.51) |
| 2023 | $1,794 | 121 | AbbVie Inc. ($310.91) |
| 2022 | $2,069 | 133 | Vanda Pharmaceuticals Inc. ($271.21) |
| 2021 | $2,434 | 177 | AbbVie Inc. ($316.02) |
| 2020 | $2,170 | 158 | AstraZeneca Pharmaceuticals LP ($324.52) |
| 2019 | $2,070 | 181 | Allergan Inc. ($270.36) |
| 2018 | $1,803 | 154 | PFIZER INC. ($245.05) |
| 2017 | $1,821 | 158 | Allergan Inc. ($222.30) |
All Payment Transactions
1,188 individual payment records from CMS Open Payments — Page 1 of 48
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: Diabetes | ||||||
| 12/10/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 12/06/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $11.25 | General |
| Category: Cardiology | ||||||
| 12/03/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/20/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 11/19/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: Diabetes | ||||||
| 11/15/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $6.35 | General |
| Category: Cardiology | ||||||
| 11/08/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: Central Nervous System | ||||||
| 11/06/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $12.46 | General |
| Category: PSYCHIATRY | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $9.71 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/31/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/30/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: PSYCHIATRY | ||||||
| 10/24/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 10/22/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Cardiology | ||||||
| 10/07/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: PSYCHIATRY | ||||||
| 09/27/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.10 | General |
| 09/26/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $4.87 | General |
| Category: PSYCHIATRY | ||||||
| 09/25/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: Inflammation | ||||||
| 09/20/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 09/11/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 35 | 1,894 | 3,347 | $286,252 | $167,423 |
| 2022 | 32 | 1,977 | 3,600 | $285,321 | $174,546 |
| 2021 | 28 | 2,053 | 4,649 | $351,845 | $215,254 |
| 2020 | 41 | 2,567 | 6,150 | $438,897 | $279,361 |
Total Patients
8,491
Total Services
17,746
Medicare Billing
$836,584
Procedure Codes
136
All Medicare Procedures & Services
136 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 155 | 155 | $19,375 | $18,617 | 96.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 124 | 204 | $35,700 | $16,634 | 46.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 160 | 283 | $35,375 | $14,922 | 42.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 92 | 331 | $23,440 | $14,372 | 61.3% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 184 | 196 | $17,640 | $13,415 | 76.0% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 57 | 295 | $17,700 | $10,823 | 61.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 51 | 160 | $12,800 | $9,442 | 73.8% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 48 | 104 | $15,600 | $8,769 | 56.2% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 51 | 139 | $18,070 | $6,904 | 38.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 22 | 80 | $8,960 | $6,848 | 76.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 59 | 97 | $9,215 | $5,786 | 62.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 38 | 53 | $7,950 | $5,024 | 63.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 17 | 20 | $5,590 | $3,918 | 70.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 156 | 290 | $14,500 | $3,805 | 26.2% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 33 | 69 | $5,037 | $3,641 | 72.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 19 | 25 | $4,750 | $3,236 | 68.1% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 38 | 38 | $4,560 | $2,881 | 63.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 90 | 91 | $2,730 | $2,605 | 95.4% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 26 | 38 | $3,724 | $2,378 | 63.9% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 53 | 54 | $1,890 | $1,679 | 88.9% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 12 | 12 | $1,800 | $1,570 | 87.2% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 28 | 33 | $1,650 | $1,307 | 79.2% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 21 | 35 | $1,750 | $1,228 | 70.1% |
| 99344 | Residence visit for new patient with moderate level of medical decision making, per day, if using time, at least 60 minutes | Office | 2023 | 11 | 11 | $2,090 | $1,173 | 56.1% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 17 | 19 | $1,995 | $1,165 | 58.4% |
About Dr. William Blume, MD
Dr. William Blume, MD is a Family Medicine healthcare provider based in Evansville, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/03/2005. The National Provider Identifier (NPI) number assigned to this provider is 1952392490.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Blume, MD has received a total of $15,897 in payments from pharmaceutical and medical device companies, with $1,736 received in 2024. These payments were reported across 1,188 transactions from 57 companies. The most common payment nature is "Food and Beverage" ($15,409).
As a Medicare-enrolled provider, Blume has provided services to 8,491 Medicare beneficiaries, totaling 17,746 services with total Medicare billing of $836,584. Data is available for 4 years (2020–2023), covering 136 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Evansville, IN
- Active Since 11/03/2005
- Last Updated 02/24/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1952392490
Products in Payments
- HETLIOZ (Drug) $962.30
- VRAYLAR (Drug) $909.21
- Ozempic (Drug) $659.54
- ENTRESTO (Drug) $659.16
- FARXIGA (Drug) $589.38
- Vascepa (Drug) $480.17
- REXULTI (Drug) $391.00
- CHANTIX (Drug) $389.30
- JARDIANCE (Drug) $335.87
- SYMBICORT (Drug) $324.97
- UBRELVY (Drug) $324.05
- LATUDA (Drug) $323.22
- INVOKANA (Drug) $282.98
- XIFAXAN (Drug) $278.22
- TRULICITY (Drug) $277.28
- NUEDEXTA (Drug) $250.36
- GEMTESA (Drug) $249.38
- VIBERZI (Drug) $249.28
- Yupelri (Drug) $241.51
- ELIQUIS (Drug) $234.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Evansville
David Schultz, M.d, M.D
Family Medicine — Payments: $756,324
Family Medicine $756,324
J Sartore, Md, MD
Family Medicine — Payments: $425,777
Family Medicine $425,777
Dr. Anthony Inzerello, M.d, M.D
Family Medicine — Payments: $315,157
Family Medicine $315,157
Carol Goodman, Md, MD
Family Medicine — Payments: $125,655
Family Medicine $125,655
Randall Oliver, M.d, M.D
Family Medicine — Payments: $75,540
Family Medicine $75,540
David Brougher, M.d, M.D
Family Medicine — Payments: $62,934
Family Medicine $62,934